Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
9
9 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- REGN7508CenvacibartPhase 312 trials
Regeneron · Atrial Fibrillation (AF), Venous Thromboembolism (VTE), Venous Thromboembolism
- REGN9933amrecibartPhase 35 trials
Regeneron · Atrial Fibrillation (AF), Peripheral Artery Disease (PAD), Venous Thromboembolism (VTE)
- AbelacimabMAA868Phase 33 trials
Anthos Therapeutics, Inc. · Atrial Fibrillation (AF), Stroke
- MilvexianJNJ-70033093, BMS-986177Phase 33 trials
Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome
- VortosiranPhase 22 trials
Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)
- AP31969Phase 21 trial
Acesion Pharma · Atrial Fibrillation (AF)
- BAY 3670549Phase 21 trial
Bayer · Atrial Fibrillation
- HBI-3000sulcardine sulfatePhase 21 trial
HUYABIO International, LLC. · Atrial Fibrillation
- PKN605Phase 21 trial
Novartis · Atrial Fibrillation
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.